Oncolytics Biotech Inc.
ONC.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.73% | -3.91% | -23.62% | -20.10% | -16.95% |
| Total Receivables | -14.70% | 30.87% | -38.57% | -93.29% | 1,424.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 78.40% | -0.43% | -16.47% | -36.19% | 8.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -11.55% | 24.62% | -15.74% | 30.46% | 34.67% |
| Total Current Assets | 7.72% | -1.95% | -22.66% | -24.22% | -9.21% |
|
|
|||||
| Total Current Assets | 7.72% | -1.95% | -22.66% | -24.22% | -9.21% |
| Net Property, Plant & Equipment | -6.49% | -7.29% | -8.69% | -4.82% | 3.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.84% | -2.30% | -21.88% | -23.35% | -8.69% |
|
|
|||||
| Total Accounts Payable | 80.06% | -28.26% | -70.22% | 291.83% | 17.84% |
| Total Accrued Expenses | -0.05% | 12.64% | -0.47% | -6.00% | 30.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.75% | 4.83% | 3.61% | 13.02% | 24.36% |
| Total Finance Division Other Current Liabilities | 95.28% | -67.21% | 210.64% | -60.65% | 296.68% |
| Total Other Current Liabilities | 95.28% | -67.21% | 210.64% | -60.65% | 296.68% |
| Total Current Liabilities | 19.82% | -13.65% | -18.06% | 26.49% | 47.99% |
|
|
|||||
| Total Current Liabilities | 19.82% | -13.65% | -18.06% | 26.49% | 47.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.40% | -9.69% | -9.11% | -7.56% | -7.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.39% | 0.10% | -6.11% | 1.31% | -1.06% |
| Total Liabilities | 10.79% | -6.92% | -12.29% | 11.97% | 15.54% |
|
|
|||||
| Common Stock & APIC | 6.68% | 1.60% | -5.20% | 1.39% | -0.53% |
| Retained Earnings | -6.73% | -1.50% | 4.51% | -3.41% | -0.52% |
| Treasury Stock & Other | -20.80% | -0.21% | 38.17% | -8.36% | 6.61% |
| Total Common Equity | -1.18% | 8.65% | -37.98% | -49.89% | -21.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.18% | 8.65% | -37.98% | -49.89% | -21.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.18% | 8.65% | -37.98% | -49.89% | -21.13% |
|
|
|||||